What We Do
We’re the independent bridge between pediatric mental health and innovation
Move Founders + Startups
We give fast, credible pediatric evidence and adoption guidance without the hiring overhead.
Support Accelerators + Venture Studios
We help portfolio companies with expert pediatric insight for diligence, growth, and credibility.
Guide Investors + Funders
We provide independent pediatric product reviews to assess safety, fit, and adoption potential.
Equip Healthcare Innovators + Product Teams
We deliver expert roadmaps to test, adapt, and scale pediatric tools for research and clinical use.
Our Why
Democratizing Pediatric Clinical Science
The expertise innovators need is often locked away in the halls of academic medicine, out of reach when the kids’ mental health crisis demands urgency. Clearview shines a light on that knowledge—making it accessible, independent, and ready to power solutions that improve kids’ lives.
Services at a glance
Services are customized to your team, flat-fee, with clearly defined deliverables—no hourly billing, no ambiguous scopes.
Big Problem: You need proof — Before funding comes proof, and you don’t yet have the credible evidence to stand behind your product.
Clear Solution: Transform uncertainty into solid study designs, ethical safeguards, and funding-ready plans.
Big Problem: You need fit — You’re unsure if your product will truly work in the real world.
Clear Solution: Map how your solution fits into actual pediatric patients, workflows, healthcare system uptake, and safety expectations.
Big Problem: You need proof AND fit — You’re juggling too many unknowns and can’t afford to waste time or money on the wrong next step.
Clear Solution: Unify proof and readiness for real-world pediatrics in a single, actionable plan with clear milestones and expert guidance.
Learn more about our services
The Clearview Advantage
Credibility = Fundability
70% of healthcare investors cite clinical validation as their top funding driver.1,2
Without it, companies systematically lose funding dollars, market adoption, trust, and clinical impact. 3,4
Our doctoral-level experts give you investor-ready pediatric validation.
Fastrack Clinical Readiness
Approximately 60% of digital health pilots stall because of barriers like poor data readiness and mismatch to real-life workflow.5,6
Failed pilots waste $500K+ on average and stall market entry.6
We clear adoption barriers early so your product scales in real clinical use.
Safety & Ethical Assurance
2 out of 3 pediatric health tools skips validation. 7
The result? Millions lost in failed partnerships and an average 6-12 month delay in funding, launch, and adoption by the market. 7,8
Our plans build safety and ethics in from the start — protecting both dollars and traction.
Impact Spotlights
Pediatric insight that works in the real world
Challenge: A pediatric team needed to evolve their chronic pain program for youth to fit youth with overlapping conditions and new science.
Our Impact: In less than three weeks, we guided updates to both parent and child content, ensuring inclusivity, developmental soundness, and behavioral science alignment.
Result: The program pivoted successfully and is now rolling out to more than 30 children’s hospitals across three continents.
Challenge: A digital health team building a pediatric VR device wasn’t sure which features would actually deliver value for kids managing symptoms.
Our Impact: We delivered strategic consultation to align the program with child development principles and optimize it for clinical and real-world fit.
Result: They sharpened strategy and successfully secured funding from an NIH-accelerator.
Challenge: A team building a pediatric resilience intervention needed expert input to refine strategy and ensure developmental and clinical soundness.
Our Impact: Clearview pediatric psychologists provided strategic consultation to align the program with child development principles and optimize it for clinical and real-world fit.
Result: The resilience intervention advanced with sharper strategy and stronger grounding in evidence-based pediatric psychology, sailing through the next funding phase and moving toward clinical adoption seamlessly.
What We Do
Provide independent PhD-level evidence and readiness guidance.
Deliver flat-fee, outcome-based roadmaps (no hidden costs).
De-risk products for real-world use with kids, families, systems, and funders.
Tailor insights to your stage: early proof, clinical readiness, or full adoption.
What We Don’t Do
Deliver direct treatment or clinical care.
Replace your internal team—we enhance and support them.
Bill by the hour or leave scope unclear (no open-ended consulting).
Push “one-size-fits-all” advice—every engagement is project-specific.
Footnotes
- Norden J., Clinical validation will save digital health’s reputation (STAT, Aug 16 2022).
- Khozin, AI in Drug Development: Clinical Validation and Regulatory Innovation Are Dual Imperatives, DIA Global Forum, June 2025
- Carroll AR, Hall M, Harris M, et al. Validation of 30-Day Pediatric Hospital Readmission Risk Prediction Models. JAMA Netw Open. 2025;8(2):e2459684. doi:10.1001/jamanetworkopen.2024.59684
- Digital Medicine Society, “Seeing the Bigger Picture: Unlocking Value for Payors and Investors,” The Playbook: Pediatric Digital Medicine, February 25, 2025, Digital Medicine Society (DiMe).
- Borges do Nascimento IJ, et al. “The global effect of digital health technologies on health workers’ competencies and health workplace: an umbrella review of systematic reviews and lexical-based and sentence-based meta-analysis.” The Lancet Digital Health, Vol. 5, No. 8, 2023, pp. e534–e544.
- Bata SA, Richardson T. Value of Investment as a Key Driver for Prioritization and Implementation of Healthcare Software. Perspect Health Inf Manag. 2018 Jan 1;15(Winter):1g. PMID: 29618963; PMCID: PMC5869444.
- Kurbatfinski S, Komanchuk J, Dosani A, Letourneau N. Validity, Reliability, Accessibility, and Applicability of Young Children’s Developmental Screening and Assessment Tools across Different Demographics: A Realist Review. Children (Basel). 2024 Jun 18;11(6):745. doi: 10.3390/children11060745. PMID: 38929324; PMCID: PMC11201752.
- Tran A., Valo P., Rouvier C., et al. “Validation of the Computerized Pediatric Triage Tool, pediaTRI, in the Pediatric Emergency Department of Lenval Children’s Hospital in Nice: A Cross-Sectional Observational Study.” Frontiers in Pediatrics, vol. 10, 2022.